Stryker Q3 net sales +10.3% to $6.1B; raises FY 2025 guidance

STRYKER CORP

2025-Q3 EPS reported $6.20 revenue$17,945,000,000

Reported EPS $2.22 (+2.8%); adjusted EPS $3.19 (+11.1%).
Organic net sales +9.5% (volume +9.1%, price +0.4%); MedSurg/Neuro +8.4% organic.
Orthopaedics organic +11.4% (ex-divested Spinal +12.5%); adjusted op margin 25.6% (+90 bps).
FY 2025 guidance raised: organic sales growth 9.8%-10.2%, adj EPS $13.50-$13.60.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.